YOLFTbeta
Codexis Inc

Codexis Inc

CDXS · NASDAQ · Healthcare / Biotechnology

1.16USD+0.20 (+21.07%)

Price History

Full chart

Market Stats

Previous Close0.9581
Open1.13
Day Range1.04 – 1.20
52-Week Range0.9583 – 2.98
Volume2.50M
Market Cap144.55M
P/E (TTM)0.00
Forward P/E149.25
EPS-0.33
Dividend Yield0.00%
Beta2.53
50-Day Avg1.57
200-Day Avg1.87

About

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Alison Moore Ph.D.
  • Employees146
  • Headquarters200 Penobscot Drive, Redwood City, CA, United States, 94063, USA
  • Websitehttps://www.codexis.com

Leadership

  • Dr. Alison Moore Ph.D.President, CEO & Director · b. 1967
  • Ms. Georgia L. ErbezCFO & Chief Business Officer · b. 1967
  • Dr. Stefan Lutz Ph.D.Chief Scientific Officer
  • Mr. Britton JimenezSenior Vice President of Sales & Marketing
  • Ms. Karen Frechou-ArmijoSenior VP & Head of Human Resources
  • Mr. John SchiffhauerSenior Vice President of Intellectual Property

Financials

Income Statement

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue12.13M25.33M50.48M82.91M107.10M123.86M88.30M31.92M35.31M41.80M48.84M50.02M60.59M68.46M69.06M104.75M138.59M70.14M59.34M70.39M
Growth (%)-+108.90%+99.26%+64.25%+29.18%+15.65%-28.71%-63.85%+10.60%+18.40%+16.82%+2.43%+21.13%+12.98%+0.87%+51.69%+32.30%-49.39%-15.39%+18.61%
Cost of Revenue1.81M8.32M13.19M16.68M27.98M41.78M30.65M14.55M9.73M6.59M9.75M14.33M12.62M15.63M13.74M22.21M38.03M12.81M16.29M9.34M
Gross Profit10.32M17.01M37.29M66.23M79.12M82.08M57.65M17.37M25.58M35.22M39.08M35.70M47.97M52.83M55.31M82.55M100.56M57.33M43.06M61.05M
Gross Margin85.11%67.16%73.87%79.88%73.87%66.27%65.29%54.41%72.45%84.25%80.03%71.36%79.17%77.17%80.10%78.80%72.56%81.74%72.55%86.73%
Operating Expense29.14M55.36M81.26M84.60M86.25M97.99M88.16M58.51M44.69M42.99M47.65M58.67M59.27M65.38M79.23M105.24M135.44M125.40M101.58M99.38M
Operating Income-18.82M-38.34M-43.97M-18.37M-7.12M-15.91M-30.51M-41.15M-19.11M-7.77M-8.56M-22.97M-11.29M-12.55M-23.92M-22.70M-34.88M-68.07M-58.52M-38.33M
Operating Margin-155.16%-151.36%-87.11%-22.15%-6.65%-12.84%-34.56%-128.90%-54.13%-18.59%-17.54%-45.92%-18.64%-18.33%-34.64%-21.67%-25.17%-97.04%-98.61%-54.46%
EBITDA-15.69M-35.46M-37.87M-12.06M681.00K-4.84M-18.10M-31.07M-12.43M-2.36M-4.02M-21.93M-10.15M-7.99M-19.37M-16.75M-26.31M-49.28M-53.41M-33.87M
EBITDA Margin-129.36%-139.97%-75.03%-14.54%0.64%-3.91%-20.49%-97.34%-35.19%-5.65%-8.23%-43.83%-16.75%-11.67%-28.04%-15.99%-18.99%-70.26%-90.00%-48.11%
Net Income-18.67M-38.98M-45.13M-20.29M-8.54M-16.55M-30.86M-41.30M-19.07M-7.58M-8.56M-23.00M-10.88M-11.94M-24.01M-21.28M-33.59M-76.24M-65.28M-43.97M
Net Income Margin-153.96%-153.86%-89.40%-24.47%-7.97%-13.36%-34.95%-129.39%-54.01%-18.13%-17.52%-45.97%-17.95%-17.43%-34.77%-20.31%-24.24%-108.69%-109.99%-62.47%
R&D17.26M35.64M45.55M54.73M52.41M61.05M56.78M31.61M22.75M20.67M22.23M29.66M29.98M33.87M44.19M55.92M80.10M58.88M46.26M52.31M
R&D as % of Total Revenue142.30%140.70%90.25%66.01%48.93%49.29%64.31%99.01%64.45%49.45%45.52%59.29%49.47%49.48%63.98%53.38%57.80%83.95%77.96%74.31%
Interest Expense724.00K2.53M2.37M2.04M529.00K675.00K274.00K304.00K18.00K19.00K60.00K147.00K671.00K5.19M4.80M7.55M1.44M12.27M10.39M4.81M
Interest Expense % of Total Revenue5.97%10.00%4.69%2.46%0.49%0.54%0.31%0.95%0.05%0.05%0.12%0.29%1.11%7.58%6.96%7.21%1.04%17.50%17.51%6.84%

Balance Sheet

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets46.66M113.54M70.88M99.04M141.30M135.92M99.97M58.84M48.12M44.65M35.65M53.63M78.28M149.07M221.65M246.38M250.39M136.56M149.01M147.80M
Total Liabilities99.42M201.01M200.01M62.20M33.94M33.23M21.52M17.36M21.81M21.77M16.55M29.08M21.98M43.56M51.54M81.99M105.60M49.95M82.08M97.27M
Total Equity-52.77M-87.47M-129.12M104.88M107.36M102.69M78.44M41.48M26.31M22.88M19.10M24.55M56.31M105.52M170.10M164.39M144.80M86.61M66.93M50.53M
Cash32.25M55.08M21.90M31.79M72.40M25.76M32.00M22.13M26.49M23.27M19.24M31.22M53.04M90.50M149.12M116.80M113.98M65.12M19.26M50.79M
Total Debt4.07M17.41M13.68M7.94M-----425.00K425.00K727.00K486.00K26.12M24.95M47.65M43.64M16.02M59.90M73.21M
Net Debt-28.17M-37.67M-8.22M-23.84M-72.40M-25.76M-32.00M-22.13M-26.49M-22.85M-18.82M-30.92M-52.98M-64.38M-124.17M-69.14M-70.35M-49.09M40.63M22.41M

Cash Flow

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.29M-6.47M-36.32M-8.69M-16.38M-490.00K-11.89M-23.00M321.00K-433.00K-2.70M-8.76M-14.09M-12.56M-16.46M-14.27M11.28M-52.64M-49.41M-19.38M
Investing Cash Flow205.00K-39.21M7.06M-21.06M-5.17M-48.81M16.71M13.27M4.65M-1.26M-842.00K-908.00K-2.77M-3.67M-5.75M-21.42M-13.58M-4.86M-56.98M23.50M
Financing Cash Flow39.71M68.38M-3.89M40.00M62.24M2.58M1.26M-147.00K-611.00K-1.52M-490.00K21.65M38.57M53.96M80.81M3.77M-575.00K8.17M60.52M27.93M
Capital Expenditure1.10M8.24M8.54M10.80M27.70M10.74M2.93M1.18M302.00K1.20M888.00K985.00K2.77M3.73M3.75M13.83M8.31M4.42M4.30M4.47M
Free Cash Flow-14.39M-14.71M-44.85M-19.48M-44.08M-11.23M-14.82M-24.17M19.00K-1.63M-3.59M-9.75M-16.86M-16.29M-20.21M-28.09M2.98M-57.06M-53.72M-23.85M
Dividends Paid-----0000000-2.85M1.26M-----
FCF to OCF108.29%227.43%123.51%224.30%269.05%2291.02%124.66%105.11%5.92%376.91%132.88%111.24%119.64%129.70%122.76%196.92%26.38%108.39%108.71%123.07%
Dividend Paid to FCF-----0.00%0.00%0.00%0.00%0.00%0.00%0.00%--17.50%-6.22%-----

Earnings

Report DateMay 27, 2010Aug 5, 2010Oct 28, 2010Feb 3, 2011May 5, 2011Jul 28, 2011Nov 1, 2011Feb 7, 2012May 10, 2012Aug 9, 2012Nov 7, 2012Feb 27, 2013May 7, 2013Aug 9, 2013Nov 12, 2013Mar 11, 2014May 7, 2014Aug 6, 2014Nov 4, 2014Mar 3, 2015May 7, 2015Aug 11, 2015Nov 4, 2015Mar 3, 2016May 9, 2016Aug 9, 2016Nov 8, 2016Mar 9, 2017May 9, 2017Aug 9, 2017Nov 9, 2017Mar 8, 2018May 10, 2018Aug 8, 2018Nov 8, 2018Feb 26, 2019May 6, 2019Aug 6, 2019Nov 5, 2019Feb 27, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 24, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 23, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Feb 28, 2024May 2, 2024Aug 8, 2024Oct 31, 2024Feb 26, 2025May 14, 2025Aug 13, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Aug 11, 2026Nov 5, 2026
EPS Estimate--0.14-0.13-0.07-0.04-0.05-0.08-0.11-0.15-0.18-0.12-0.36-0.33-0.28-0.31-0.21-0.10-0.15-0.060.01-0.11-0.14-0.06-0.04-0.140.04-0.13-0.11-0.14-0.12-0.150.05-0.08-0.08-0.03-0.03-0.08-0.07-0.050.05-0.15-0.13-0.05-0.12-0.18-0.12-0.05-0.22-0.15-0.12-0.16-0.23-0.25-0.14-0.26-0.12-0.14-0.24-0.21-0.04-0.21-0.15-0.13-0.04-0.10-0.17-0.09
EPS Actual-0.50-0.15-0.08-0.01-0.10-0.14-0.08-0.15-0.21-0.15-0.06-0.41-0.25-0.33-0.24-0.26-0.17-0.22-0.120.01-0.14-0.140.13-0.05-0.170.050.03-0.13-0.18-0.13-0.210.02-0.05-0.02-0.04-0.01-0.05-0.080.040.02-0.13-0.07-0.06-0.06-0.09-0.010.03-0.16-0.13-0.04-0.15-0.14-0.34-0.17-0.31-0.10-0.16-0.32-0.29-0.13-0.25-0.16-0.220.14-0.10-0.13-
Surprise--7.14%38.46%85.71%-150.00%-180.00%0.00%-36.36%-40.00%16.67%50.00%-13.89%24.24%-17.86%22.58%-23.81%-70.00%-46.67%-100.00%0.00%-27.27%0.00%316.67%-25.00%-21.43%25.00%123.08%-18.18%-28.57%-8.33%-40.00%-60.00%37.50%75.00%-33.33%66.67%37.50%-14.29%180.00%-60.00%13.33%46.15%-20.00%50.00%50.00%91.67%160.00%27.27%13.33%66.67%6.25%39.13%-36.00%-21.43%-19.23%16.67%-14.29%-33.33%-38.10%-225.00%-19.05%-6.67%-69.23%485.44%0.00%23.53%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap144.55M
Enterprise Value170.43M
Trailing P/E0.00
Forward P/E149.25
PEG Ratio13.53
Price / Sales1.86
Price / Book4.63
EPS-0.33
Book Value0.361
Revenue (TTM)77.68M
Gross Profit (TTM)18.85M
EBITDA-19.05M
Profit Margin-39.55%
Operating Margin-75.29%
Return on Equity-69.36%
Return on Assets-11.74%
Shares Outstanding109.51M
Shares Float82.35M
Beta2.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 7 analystsTarget 6.14
  • Strong Buy
    4
  • Buy
    1
  • Hold
    2

Ownership Breakdown

Institutions
70.49%
Insiders
7.12%
Retail / Other
22.39%

Top Institutional Holders

  • BlackRock Inc
    7.03M6.43%
  • Opaleye Management Inc
    6.79M6.20%
  • Aberdeen Group PLC
    6.77M6.19%
  • Millennium Management LLC
    5.55M5.07%
  • Nantahala Capital Management, LLC
    4.12M3.77%
  • Telemark Asset Management, LLC
    3.85M3.52%
  • Vanguard Capital Management, LLC
    3.67M3.35%
  • Ameriprise Financial Inc
    3.40M3.11%
  • UBS Group AG
    2.18M2.00%
  • Geode Capital Management, LLC
    1.89M1.72%
  • State Street Corp
    1.67M1.52%
  • D. E. Shaw & Co LP
    1.34M1.23%
  • Assenagon Asset Management SA
    1.28M1.17%
  • Jacobs Levy Equity Management, Inc.
    1.09M0.99%

Top Fund Holders

  • abrdn Healthcare Investors
    7.01M6.41%
  • abrdn Life Sciences Investors
    3.79M3.46%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.08M2.81%
  • Columbia Small Cap Value Discv A
    2.66M2.43%
  • iShares Russell 2000 ETF
    2.25M2.06%
  • Fidelity Small Cap Index
    938.81K0.86%